Zobrazeno 1 - 10 of 60 pro vyhledávání: '"Robert W. Marquis"'
1
Akademický článek
MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates
Autor: Yves Dondelinger, Wim Declercq, Sylvie Montessuit, Ria Roelandt, Amanda Goncalves, Inge Bruggeman, Paco Hulpiau, Kathrin Weber, Clark A. Sehon, Robert W. Marquis, John Bertin, Peter J. Gough, Savvas Savvides, Jean-Claude Martinou, Mathieu J.M. Bertrand, Peter Vandenabeele
Publikováno v: Cell Reports, Vol 7, Iss 4, Pp 971-981 (2014)
Although mixed lineage kinase domain-like (MLKL) protein has emerged as a specific and crucial protein for necroptosis induction, how MLKL transduces the death signal remains poorly understood. Here, we demonstrate that the full four-helical bundle d
Externí odkaz: https://doaj.org/article/861d16d1f33d45d7a36b240ef8000808
Zobrazit plný text záznamu
2
Understanding Pharmacokinetic Disconnect in Preclinical Species for 4-Aminoquinolines: Consequences of Low Permeability and High P-glycoprotein Efflux Ratio on Rat and Dog Oral Pharmacokinetics
Autor: Bartholomew J. Votta, Michael Reilly, Linda N. Casillas, Robert W. Marquis, Rakesh Nagilla, Mukesh K. Mahajan, Demartino Michael P, John Bertin, Helen H. Sun, Elizabeth J. Rivera, Pamela A. Haile
Publikováno v: Journal of Pharmaceutical Sciences. 109:3160-3171
Receptor Interacting Protein 2 (RIP2) kinase inhibitors have been reported for therapeutic opportunities in inflammatory bowel diseases such as Ulcerative Colitis and Crohn's disease. During lead optimization, team identified 4-aminoquinoline series
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37e4b5f428c4f553af936801d030b6de
https://doi.org/10.1016/j.xphs.2020.06.013
Zobrazit plný text záznamu
4
Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase
Autor: Stéphane Sautet, Emilie Jigorel, Nicolas Faucher, Jamel Meslamani, Lara Kathryn Leister, Pascal Grondin, Julie A. Cox, Bryan W. King, Pamela Nassau, Gemma Victoria White, Brad J. Geddes, Alain Claude-Marie Daugan, Helen H. Sun, Michael T. Ouellette, Pauline Lamoureux, Elizabeth J. Rivera, Scott B. Berger, James H. Thorpe, Philip A. Harris, J. Mosley, Susan E. Hutchinson, Frédéric Donche, John Bertin, Sandra J. Hoffman, Natalie Wellaway, Patrick M. Eidam, Paris Ward, Florent Potvain, Clark A. Sehon, Sebastien Andre Campos, Robert W. Marquis, Peter J. Gough, Mukesh K. Mahajan, Veronique Beneton, Jae U. Jeong, Michelle C. Schaeffer, John D. Lich, Allison M. Beal, Rakesh Nagilla, James Michael Woolven, Bonnie L. Hoffman, Anderson Niall Andrew, Marie-Hélène Fouchet, Deepak Bandyopadhyay, Carol A. Capriotti, Rachel D. Totoritis, Joshua N. Finger, Kishore K. Pasikanti, David D. Wisnoski, Sze-Ling Ng, Nino Campobasso, Nicolas George, Michael Reilly
Publikováno v: Journal of Medicinal Chemistry. 62:5096-5110
RIP1 kinase regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including inflammatory and neurological diseases. Currently, RIP1 kinase inhibitors have advanced into early clinical
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49ff65b82b2e1feff6acc28b9dcac4dc
https://doi.org/10.1021/acs.jmedchem.9b00318
Zobrazit plný text záznamu
5
Akademický článek
Identification of selective small molecule inhibitors of the nucleotide-binding oligomerization domain 1 (NOD1) signaling pathway.
Autor: David J Rickard, Clark A Sehon, Viera Kasparcova, Lorena A Kallal, Pamela A Haile, Xin Zeng, Monica N Montoute, Derek D Poore, Hu Li, Zining Wu, Patrick M Eidam, John G Emery, Robert W Marquis, Peter J Gough, John Bertin
Publikováno v: PLoS ONE, Vol 9, Iss 5, p e96737 (2014)
NOD1 is an intracellular pattern recognition receptor that recognizes diaminopimelic acid (DAP), a peptidoglycan component in gram negative bacteria. Upon ligand binding, NOD1 assembles with receptor-interacting protein (RIP)-2 kinase and initiates a
Externí odkaz: https://doaj.org/article/d8966b29a270430a972aa590bfa33f4f
Zobrazit plný text záznamu
6
Overcoming the Pregnane X Receptor Liability: Rational Design to Eliminate PXR-Mediated CYP Induction
Autor: Ami S. Lakdawala, Shawn P. Williams, Demartino Michael P, Ramanjulu Joshi M, Yunfeng Lan, Robert W. Marquis
Publikováno v: ACS Med Chem Lett
[Image: see text] The pregnane X receptor (PXR) regulates expression of proteins responsible for all three phases required for the detoxification mechanism, which include CYP450 enzymes, phase II enzymes, and multidrug efflux pumps. Therefore, PXR is
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84549be94c9b79941145ba5ddc1e2096
https://pubmed.ncbi.nlm.nih.gov/34531948
Zobrazit plný text záznamu
7
Akademický článek
Identification of benzimidazole diamides as selective inhibitors of the nucleotide-binding oligomerization domain 2 (NOD2) signaling pathway.
Autor: David J Rickard, Clark A Sehon, Viera Kasparcova, Lorena A Kallal, Xin Zeng, Monica N Montoute, Tushar Chordia, Derek D Poore, Hu Li, Zining Wu, Patrick M Eidam, Pamela A Haile, Jong Yu, John G Emery, Robert W Marquis, Peter J Gough, John Bertin
Publikováno v: PLoS ONE, Vol 8, Iss 8, p e69619 (2013)
NOD2 is an intracellular pattern recognition receptor that assembles with receptor-interacting protein (RIP)-2 kinase in response to the presence of bacterial muramyl dipeptide (MDP) in the host cell cytoplasm, thereby inducing signals leading to the
Externí odkaz: https://doaj.org/article/5e593a2a329d48da9774642aa0357266
Zobrazit plný text záznamu
10
Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer
Autor: Joshua N. Finger, Michael T. Ouellette, Helen H. Sun, Robert W. Marquis, Viera Kasparcova, James H. Thorpe, Scott B. Berger, Philip A. Harris, Rakesh Nagilla, George Miller, Anirudh Chirala, James Kang, Elizabeth J. Rivera, John Bertin, Peter J. Gough, Mukesh K. Mahajan, Daohua Zhang, John D. Lich, Julie A. Cox, Wei Wang, Lara Kathryn Leister, Jill M. Marinis, Rachel D. Totoritis, Patrick M. Eidam, Michael Reilly, Jae U. Jeong, Dongling Wu, Alan R. Rendina
Publikováno v: ACS Medicinal Chemistry Letters
'ACS Medicinal Chemistry Letters ', vol: 10, pages: 857-862 (2019)
RIP1 regulates cell death and inflammation and is believed to play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases and cancer. While small-molecule inhibitors of RIP1 kinase have be
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc54611512d75002b3dd48f05749d17f
https://pubmed.ncbi.nlm.nih.gov/31223438
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje